Literature DB >> 12368310

Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells.

Hang Yuan1, Tim Veldman, Kathleen Rundell, Richard Schlegel.   

Abstract

Human keratinocytes immortalized by full-length or early-region simian virus 40 (SV40) DNA grow in agarose and form tumors in nude mice, in contrast to keratinocytes immortalized by the E6/E7 genes of human papillomaviruses. To determine the molecular basis for this biological difference in growth, we have used the individual SV40 oncogenes (large T antigen [LT] and small t antigen [st]) and human papillomavirus oncogenes (E6/E7) to study the progression of human epithelial cells from the nonimmortal to the immortal state as well as from the immortal to the anchorage-independent state. Transfection of primary human foreskin keratinocytes with LT did not immortalize cells but did extend the in vitro life span and produced cells that were resistant to calcium- and serum-induced terminal differentiation. Cells transfected with st alone did not passage beyond vector-transfected keratinocytes. The simultaneous expression of LT- and st-immortalized keratinocytes occurred without evidence of crisis and, as anticipated, these immortal cells were anchorage- independent for growth. Interestingly, we found that keratinocytes expressing both LT and st, but not keratinocytes with LT alone, exhibited increased phosphorylation of the protein kinase AKT. In addition, AKT activation was paralleled by an increase in telomerase activity. Addition of st to anchorage-dependent keratinocytes, expressing either LT (nonimmortal) or E6/E7 (immortal), converted the cells to anchorage independence, with similar accompanying increases in AKT phosphorylation and telomerase activity. However, it was not possible to induce keratinocyte growth in agarose with activated AKT and/or overexpressed hTERT, indicating that these newly defined st-induced activities are not sufficient for progression to the anchorage-independent state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368310      PMCID: PMC136600          DOI: 10.1128/jvi.76.21.10685-10691.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen.

Authors:  J W Shay; W E Wright
Journal:  Exp Cell Res       Date:  1989-09       Impact factor: 3.905

2.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

3.  SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen.

Authors:  I Bikel; X Montano; M E Agha; M Brown; M McCormack; J Boltax; D M Livingston
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

4.  Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes.

Authors:  R R Reddel; Y Ke; B I Gerwin; M G McMenamin; J F Lechner; R T Su; D E Brash; J B Park; J S Rhim; C C Harris
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

5.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Transformation and immortalization of diploid xeroderma pigmentosum fibroblasts.

Authors:  B Klein; A Pastink; H Odijk; A Westerveld; A J van der Eb
Journal:  Exp Cell Res       Date:  1990-12       Impact factor: 3.905

7.  Inhibition of SV40 large T antigen induced apoptosis by small T antigen.

Authors:  T Kolzau; R S Hansen; D Zahra; R R Reddel; A W Braithwaite
Journal:  Oncogene       Date:  1999-09-30       Impact factor: 9.867

8.  Control of protein phosphatase 2A by simian virus 40 small-t antigen.

Authors:  S I Yang; R L Lickteig; R Estes; K Rundell; G Walter; M C Mumby
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

9.  A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region.

Authors:  A Bellacosa; J R Testa; S P Staal; P N Tsichlis
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

10.  Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma.

Authors:  R Schlegel; W C Phelps; Y L Zhang; M Barbosa
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  32 in total

1.  Identification of PP2A complexes and pathways involved in cell transformation.

Authors:  Anna A Sablina; Melissa Hector; Nathalie Colpaert; William C Hahn
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

2.  Comparisons between murine polyomavirus and Simian virus 40 show significant differences in small T antigen function.

Authors:  Shaida Andrabi; Justin H Hwang; Jennifer Kean Choe; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements.

Authors:  Bi-He Cai; Chung-Faye Chao; Hwang-Chi Lin; Hua-Ying Huang; Reiji Kannagi; Jang-Yi Chen
Journal:  J Biochem       Date:  2016-01-27       Impact factor: 3.387

4.  Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control.

Authors:  Pablo Rodriguez-Viciana; Crista Collins; Mike Fried
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

Review 5.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

6.  Restricted protein phosphatase 2A targeting by Merkel cell polyomavirus small T antigen.

Authors:  Hyun Jin Kwun; Masahiro Shuda; Carlos J Camacho; Armin M Gamper; Mamie Thant; Yuan Chang; Patrick S Moore
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

7.  Transformation with oncogenic Ras and the simian virus 40 T antigens induces caspase-dependent sensitivity to fatty acid biosynthetic inhibition.

Authors:  Shihao Xu; Cody M Spencer; Joshua Munger
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

8.  Inhibition of Cullin-RING E3 ubiquitin ligase 7 by simian virus 40 large T antigen.

Authors:  Thomas Hartmann; Xinsong Xu; Mira Kronast; Susanne Muehlich; Kathleen Meyer; Wolfgang Zimmermann; Jerard Hurwitz; Zhen-Qiang Pan; Stefan Engelhardt; Antonio Sarikas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

9.  Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation.

Authors:  Sravanth Hindupur Kumar; Annapoorni Rangarajan
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

10.  JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity.

Authors:  Brigitte Bollag; Catherine A Hofstetter; Marta M Reviriego-Mendoza; Richard J Frisque
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.